COPYRIGHT 2020 POSVAX CO. LTD. ALL RIGHTS RESERVED.
r&d
Prophylactic Vaccines
RSV Vaccines
Respiratory syncytial virus (RSV) is a virus causing rapid respiratory infection to people with low immunity including infants and the elderly. To infants, it can cause bronchitis and pneumonia, and even to death.
Process of pneumonia
RSV VaccinesHighlights
POSVAX RSV VACCINES
FEATURES
VLP-based prophylactic vaccines
Excellent immunogenicity and safety
STATE OF DEVELOPMENT
VLP manufacturing process developed
EFFICACY
Prevent bronchitis and pneumonia
Decrease hospitalization and death rates of infants
FUTURE MARKET
VLP based RSV vaccine is highly potential vaccine platform